Session I: Continuous Manufacturing of Pharmaceuticals - Why and Why Now?
Schedule:
TIME |
PRESENTATION |
SPEAKER |
|
8:50 - 9:30 |
Talk 1: Continuous Manufacturing: Achieving the Vision of Modernizing Pharmaceutical Manufacturing |
Christine Moore, PhD, US Food and Drug Administration |
|
9:40 - 10:20 |
Talk 2: Approaches to Regulatory Engagement and Filing for Continuous Manufacturing |
Mark Buswell, PhD, Head, Advanced Manufacturing Technologies, Glaxo Smith Kline |
|
10:40 - 11:20 |
Talk 3: Powders to Tablets in Minutes: Implementation of a Portable, Continuous, Miniature, and Modular (PCMM) Factory in a Warehouse |
Mike O’Brien, PhD, Vice President Technology and Innovation, Pfizer |
|
11:20 - 12:00 |
Talk 4: Design and Implementation of a Small Footprint Continuous API facility for Portfolio Commercialization |
Eoin McManus, Business Leader, Small Molecule Operations, Eli Lilly Ireland |